Since 2024: Glaring Reality Keeps AbbVie on Hold
AbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
Knowing when to save and when to invest is crucial for financial success. Learn how to optimize your strategy for maximum returns.
28,655 articlesAbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
A structural shift in corporate spending is reshaping personal finances. Wages rise, but profits and cash flow are in...
A decade into AI-driven demand, Marvell and Micron have shown how long-term bets on data infrastructure and memory ca...
OpenAI is quietly pitching its products to U.S. military and national security clients, a move that could reshape fun...
C.H. Robinson is pursuing a Lean AI powered transformation led by CEO Dave Bozeman, aiming to turn the freight broker...
Federal agencies are deploying Anthropic’s Mythos to hunt bugs in critical code, a move that broadens AI’s role in na...
Tech shares lift global markets as oil slips on Iran tensions. AI-driven leaders propelled gains across major indexes...
An executive chair's sizable stock sale draws attention. This piece explains what the numbers mean, how to read insid...
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
As investors hunt for catalysts in 2026, the idea of a blockbuster stock split from Booking Holdings stands out. This...
Portland launches a yearlong room rental pilot to test Oregon's new SRO rules. The program provides incentives to lan...
A new Iran clash sends shockwaves through global travel, with 23,000 cancelled flights debris and mass disruptions ac...